Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: In vitro and in vivo evaluation

Current Drug Delivery

Volumn 9, Issue 2, 2012, Pages 172-181

  Aggarwal, Geeta ^a   Dhawan, Sanju ^b   Harikumar, S L ^a  

^a INSTITUTE OF NANO SCIENCE AND TECHNOLOGY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Antipsychotic; Corn oil; Eudragit; Groundnut oil; Olanzapine; Permeation enhancer; Transdermal delivery

Indexed keywords

ARACHIS OIL; CORN OIL; EUDRAGIT; EXCIPIENT; JOJOBA OIL; OLANZAPINE; PENETRATION ENHANCING AGENT; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EXCIPIENT COMPATIBILITY; EXPERIMENTAL RABBIT; FEMALE; GRIP STRENGTH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SKIN PENETRATION; SKINFOLD THICKNESS; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSDERMAL PATCH;

EID: 84857829296     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720112800234567     Document Type: Article

References (41)

1. Shore, D. Recent developments in atypical antipsychotic medications. Schizophr. Bull., 1998, 24(1), 33.
2. Stahl, M.; Grady, M.M. Critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr. Med. Chem., 2004, 11(3), 313-327.
3. Keck, P.E.; Mcelory, S.L. Clinical pharmacodynamics and phar-macokinetics of antimaniac and mood stabilizing medications. J. Clin. Psychiat., 2002, 63(4), 3-11.
4. Wertheimer, A.I.; Santella, T.M.; Finestone, A.J.; Levy, R.A. Drug delivery systems improve pharmaceutical profile and facilitate medication adherence. Adv. Ther., 2005, 22(6), 559-576.
5. Li, L.; Fang, L.; Xu, X.; Liu, Y.; Sun, Y.; He, Z. Formulation and biopharmaceutical evaluation of a transdermal patch containing le-trozole. Biopharm. Drug Dispos., 2010, 31, 138-149.
6. Escobar-Chávez, J.J.; Merino, V.; Díez-Sales, O.; Nácher-Alonso, A.; Ganem-Quintanar, A.; Herráez, M.; Merino-Sanjuán, M. Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation. Pharm. Dev. Technol., 2011, 16, 162-169.
7. Swain, K.; Pattnaik, S.; Sahu, S.C.; Patnaik, K.K.; Mallick, S. Drug in adhesive type transdermal matrix systems of ondansetron hydro-chloride: optimization of permeation pattern using response surface methodology. J. Drug Target., 2010, 18(2), 106-114.
8. Charoo, N.A.; Anwer, A.; Kohli, K.; Pillai, K.K.; Rahman, Z. Transdermal delivery of flurbiprofen: Permeation enhancement, Design, Pharmacokinetic and Pharmacodynamic studies in albino rats. Pharm. Dev. Technol., 2005, 10(3), 343-351.
9. Setty, C.M.; Jawarkar, Y.; Pathan, I.B. Effect of essential oils as permeation enhancers on percutaneous penetration of furosemide through human cadaver skin. Acta Pharmaceut. Sciencia, 2010, 52, 159-168.
10. Jain, R.; Aqil, M.; Ahad, A.; Ali, A.; Khar, R.K. Basil Oil is a promising skin penetration enhancer for transdermal delivery of la-betolol hydrochloride. Drug Dev. Ind. Pharm., 2008, 34, 384-389.
11. Mittal, A.; Parmar, S.; Singh, B. In vitro and in vivo assessment of matrix type transdermal therapeutic system of labetalol hydrochlo-ride. Curr. Drug Deliv., 2009, 6(5), 511-519.
12. Chandra, A.; Sharma, P.K. Transdermal delivery of ketorolac. Yakugaku Zasshi, 2009, 129(3), 373-379.
13. Ren, C.; Fang, L.; Ling, L.; Wang, Q.; Liu, S.; Zhao, L.; He, Z. Design and in vivo evaluation of an indapamide transdermal patch. Int. J. Pharm., 2009, 370, 129-135.
14. De, P.; Damodharan, N.; Mallick, S.; Mukherjee, B. Development and evaluation of nefopam transdermal matrix patch system in human volunteers. PDA J. Pharm. Sci. Technol., 2009, 63, 537-546.
15. Chandak, A.R.; Verma, P.R.P. Eudragit based transdermal delivery system of Pentazocin: Phycochemical, in vitro and in vivo evaluations. Pharm. Dev. Technol., 2010, 15, 296-304.
16. Gannu, R.; Vishnu, Y.V.; Kishan, V.; Rao, Y.M. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties. PDA J. Pharm. Sci. Technol., 2008, 62(6), 391-401.
17. Mittal, A.; Sara, U.S.; Ali, A.; Mohammed, A. Design, development, physicochemical, in vitro, and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine. Pharm. Dev. Technol., 2009, 14(4), 422-434.
18. Jain, P.; Banga, A.K. Inhibition of crystallization in drug-inadhesive-type transdermal patches. Int. J. Pharm. 2010, 394, 68-74.
19. Gullick, D.R.; Pugh, W.J.; Ingram, M.J.; Cox, P.A.; Moss, G.P. Formulation and characterization of a captopril ethyl ester drug-inadhesive-type patch for percutaneous absorption. Drug Dev. Ind. Pharm., 2010, 36 (8), 926-932.
20. Yener, G.; Uner, M.; Gonullu, U.; Yildirim, S.; Kilic, P.; Aslan, S.S.; Barla, A. Design of meloxicam and lornoxicam transdermal patches: preparation, physical characterization, ex vivo and in vivo studies. Chem. Pharm. Bull., 2010, 58(11), 1466-1473.
21. Mundargi, R.C.; Patil, S.A.; Agnihotri, S.A.; Aminabhavi, T.M. Evaluation and controlled release characteristics of modified xan-than films for transdermal delivery of atenolol. Drug Dev. Ind. Pharm., 2007, 33, 79-90.
22. Jayaprakash, S.; Halith, S.M.; Firthouse, P.M.; Nagarajan, Y.M. Preparation and evaluation of celecoxib transdermal patches. Pak. J. Pharm. Sci., 2010, 23(3), 279-283.
23. Zhang, G.; Terry Jr, A.V.; Bartlett, M.G. Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection. J. Chromatogr. B, 2007, 856, 20-28.
24. Samanta, M.K.; Dube, R.; Suresh, B. Transdermal drug delivery system of haloperidol to overcome self induced extrapyramidal syndrome. Drug Dev. Ind. Pharm., 2003, 29, 405-415.
25. Hai, N.T.; Kim, J.; Park, E.S.; Chi, S.C. Formulation and biophar-maceutical evaluation of transdermal patch containing benztropine. Int. J. Pharm., 2008, 357, 55-60.
26. Dusci, L.J.; Hackett, L.P.; Fellows, L.M.; Ilett, K.F. Determination of olanzapine in plasma by high performance liquid chromatogra-phy using ultraviolet absorbance detection. J. Chromatogr. B, 2002, 773, 191-197.
27. Sun, Y.; Fang, L.; Zhu, M.; Li, W.; Meng, P.; Li, L.; He, Z. A drug-in-adhesive transdermal patch for S-amlodipine free base: In vitro and in vivo characterization. Int. J. Pharm., 2009, 382, 165-171.
28. Charoo, N.A.; Shamsher, A.A.A.; Kohli, K.; Pillai, K.; Rahman, Z. Improvement in bioavailability of transdermally applied flurbipro-fen using tulsi (ocimum sanctum) and turpentine oil. Colloids Surf. B: Biointerfaces., 2008, 65, 300-307.
29. Ubaidulla, U.; Reddy, M.V.S.; Ruckmani, K.; Ahmad, F.J.; Khar, R.K. Transdermal therapeutic system of carvedilol: Effect of hy-drophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech., 2007, 8, E1-E8.
30. Alam, M.I.; Baboota, S.; Kohli, K.; Ali, J.; Ahuja, A. Development and evaluation of transdermal patches of celecoxib. PDA J. Pharm. Sci. Technol., 2009, 63, 429-437.
31. Mutalik, S.; Udupa, N. Glibenclamide transdermal patches: Phys-icochemical, pharmacodynamic and pharmacokinetic evaluations. J. Pharm. Sci., 2004, 93, 1577-1594.
32. Draize, J.H.; Woodard, G.; Calvery, H.O. Methods for the study of irritation and toxicity of substances applied to skin and mucous membranes. J. Pharmacol. Exp. Ther. 1994, 82, 377-390.
33. Aggarwal, G.; Garg, A.; Dhawan, S. Transdermal drug delivery: Evolving technologies and expanding opportunities. Ind. J. Pharm. Educ. Res., 2009, 43(3), 251-259.
34. Kanikkannan, N.; Kandimalla, K.; Lamba, S.S.; Singh, M. Structure activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem., 2000, 7(6), 593-608.
35. Dupont, J.; White, P.J.; Carpenter, M.P.; Schaefer, E.J.; Meydani, S.N.; Elson, C.E.; Woods, M.; Gorbach, S.L. Food uses and health effects of corn oil. J. Am. Coll. Nutr., 1990, 9, 438-470.
36. Jamieson, G.S.; Baughman, W.F.; Brauns, D.H. The chemical composition of peanut oil. J. Am. Chem. Soc., 1921, 43, 1372-1381.
37. Wang, L.H.; Wang, C.C.; Kuo, S.C. Vehicle and enhancer effects on human skin penetration of aminophylline from cream formulations. J. Cosmet. Sci., 2007, 58, 245-254.
38. Sinha, V.R.; Kaur, M.P. Permeation enhancer for transdermal drug delivery. Drug Dev. Ind. Pharm., 2000, 26, 1131-1140.
39. Benson, H.A.E. Transdermal drug delivery; Penetration enhancement techniques. Curr. Drug Deliv., 2005, 2, 23-33.
40. Yamashita, F.; Hashida, M. Mechanistic and empirical modeling of skin permeation of drugs. Adv. Drug Deliv. Rev., 2003, 55, 1185-1199.
41. Sanap, G.S.; Dama, G.Y.; Hande, A.S.; Karpe, S.P.; Nalawade, S.V.; Kakade, R.S.; Jadhav, U.Y. Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer. Int. J. Green Pharm., 2008, 2, 129-133.